With an array of new medicines and medical devices on display, global medical companies are looking to tap further into the ...

With an array of new medicines and medical devices on display global medical companies are looking to tap further into the ...

"China market is one of the most attractive markets for Edwards," said Leo Tam, senior director of the business unit of Transcatheter Aortic Valve Replacement, Edwards Lifesciences China, citing a lot ...

Illumina, a United States-headquartered company specializing in DNA sequencing and array-based technologies, is showcasing ...

The Supreme Court of California is gearing up to decide an important question for the future of product liability law: Do drug manufacturers have ...

exceeding the Medical sector's loss of 4.09% and the S&P 500's gain of 1.67%. Investors will be eagerly watching for the performance of Gilead Sciences in its upcoming earnings disclosure.

exceeding the Medical sector's loss of 4.16% and the S&P 500's gain of 2.68%. Investors will be eagerly watching for the performance of Gilead Sciences in its upcoming earnings disclosure.

In the latest quarter, 15 analysts provided ratings for Gilead Sciences GILD, showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ratings, shedding ...

Gilead Sciences (GILD) has been one of the most searched ... During this period, the Zacks Medical - Biomedical and Genetics industry, which Gilead falls in, has lost 1.9%. The key question ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its third quarter 2024 financial results and guidance will be released on Wednesday, November 6 ...

About Gilead Sciences, Inc. Gilead Sciences ... Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.